Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacyclics (PCYC) -- Ignore unavailable to you. Want to Upgrade?

To: mauser96 who wrote (444)	5/19/1999 12:07:00 PM
From: tnsaf	Read Replies (2) \| Respond to of 717

Some time ago there was mention of a company using radiation to prevent restenosis after angioplasty by killing smooth muscle cells that proliferate to clog the artery. Page 20 of the May 8 issue of New Scientist has a short article on a drug, 5-amino laevulinic acid, that sensitizes tissues to breakdown by laser and accomplishes the same end. This treatment has been used used by a team at the National Medical Laser Centre at University College London to treat patients, with arteries remaining clear six months later in all treated patients. Jason